Publications
June 22, 2022
Care Navigation at Harm Reduction Programs: Community-Based “Meds First” Buprenorphine Program Preliminary Data
ADAI Report by Susan Kingston & Caleb Banta-Green In 2019, the Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington launched the “Meds First” program to provide onsite, low-barrier access to buprenorphine in partnership with six syringe services programs across WA State. A key component of the Meds First service model was the…
May 13, 2022
New Research: Negative Attitudes About Medications for OUD Among Criminal Legal Staff
Stigma is a barrier to the treatment of opioid use disorder (OUD) in the criminal legal system, and how staff think about criminal involvement and addiction in general might explain their negative attitudes about medications for OUD (MOUD), such as buprenorphine or methadone, as well. This new paper, coauthored by ADAI Assistant Professor Mandy Owens,…
May 4, 2022
New from ADAI: Using Alcohol & Cannabis Simultaneously More Harmful for Youth Than Use of Either Alone
Using alcohol and cannabis simultaneously – taking them at the same time to generate overlapping effects – produces greater negative consequences than use of either substance alone, according to this new scoping review published in Alcohol Research: Current Reviews. For this review, researchers from the UW Center for the Study of Health and Risk Behaviors…
April 27, 2022
New from ADAI: Policy Codesign Method Effective for Development of Jail-Based Re-Entry Program for Adults with OUD
This new paper, by ADAI Assistant Professor Mandy Owens and colleagues, reports on the use of a policy codesign process to develop a jail-based re-entry program for adults with opioid use disorder (OUD) in a rural county in the U.S. Researchers hoped that the codesign process, which included folks from the jail, local health department,…
April 20, 2022
New Research: Social Equity Impact of Location of Licensed & Unlicensed Cannabis Outlets in LA County
Many states that have legalized retail sale of cannabis have been adding social equity provisions to try to redress inequities experienced by low-income and Black, Indigenous, and people of color (BIPOC) who have been disproportionately harmed by cannabis prohibition. Los Angeles County (LA) has taken the approach of increasing cannabis outlet licensure and employment for…
April 19, 2022
New Guide for Friends/Family: How to Ask If They’re Getting Addicted
Worried about someone’s drinking or drug use, but not sure what to say? This new guide in Psyche, written by ADAI research scientist K. Michelle Peavy, PhD, describes a counseling approach that can help: Community Reinforcement Approach and Family Counseling (CRAFT). Many people who want to talk with someone about their drinking or drug use…
April 6, 2022
ADAI Report: Methadone: An Old Medication with Untapped Potential
Learn about methadone, a medication long used in the U.S. as a treatment for opioid use disorder, in this new report, Methadone: An Old Medication with Untapped Potential, by ADAI research scientists K. Michelle Peavy, PhD and Caleb Banta-Green, PhD, MPH, MSW. The report explains what methadone is and how it works, as well as…
March 30, 2022
New ADAI Research: Cannabis Store Location and Advertising Influences Use by Oregon Youth
This new paper in Health and Place, led by Caislin Firth and in collaboration with the Oregon Health Authority, looks at the impact of retail cannabis store location and exposure to cannabis advertising on youth cannabis use. The project was partially funded by the National Institutes of Drug Abuse awarded to co-author Julia Dilley and the Horowitz Foundation…
March 8, 2022
Results from the 2021 WA State Syringe Service Program Health Survey
The biennial WA State Syringe Service Program Health Survey is the state’s primary source of data on the substance use patterns, health behaviors, and health care needs of people who use drugs and utilize syringe service programs (SSPs). The University of Washington’s Addictions, Drug & Alcohol Institute (ADAI) conducts the survey in collaboration with Public…
February 16, 2022
New from ADAI/FADU: Prenatal Alcohol Exposure and Mental Health at Midlife
The effects of prenatal alcohol exposure (PAE) have been studied a lot, with a particular focus on physical birth defects and neurocognitive development. Much less studied has been an association between PAE and mental health disorders, especially for adults with both PAE and fetal alcohol spectrum disorders (FASD). Though some research has found a connection…
Previous page Next page
